
“23andMe Inc., the Google Inc.-backed DNA analysis company co-founded by Anne Wojcicki, was told by U.S. regulators to halt sales of its main product because it’s being sold without ‘marketing clearance or approval.’ The Saliva Collection Kit and Personal Genome Service, or PGS, tells users whether they carry a disease, are at risk of a disease and would respond to a drug. Most of the uses fall into the category of a medical device and require Food and Drug Administration approval, the agency told the Mountain View, California-based company in a Nov. 22 letter made public today.”
Related posts:
Glenn Greenwald: Iraqi-American is imprisoned by US for saving his family from US sanctions
New Zealand: U.S. can extradite Megaupload founder Kim Dotcom
Schoolgirl virginity tests prompt outrage in Indonesia
NJ State Police dashboard camera shows confrontation with county police
Baltimore guard pleads guilty to drug smuggling racket in jail scandal
Japan to adopt 'bail-ins,' force bank losses on investors if needed, Nikkei says
Myanmar faces big setbacks to implement stock exchange
Ron Paul: NSA's PRISM Is An Awakening Call
Lyxor says it had ‘no choice’ in closure of Greek ETF
Supreme court cellphone case puts free speech – not just privacy – at risk
Egypt declares month-long state of emergency over violence
Why going to 7-Eleven has become a political act
CIA admits to helping overthrow Iran’s democratically elected leader in 1953
Merkel's party opposes Europe referendums, German lawmaker says
Combat stress felt far from front lines